Literature DB >> 13581015

The Stuart-Prower factor assay and its clinical significance.

F BACHMANN, F DUCKERT, F KOLLER.   

Abstract

Keywords:  BLOOD COAGULATION

Mesh:

Substances:

Year:  1958        PMID: 13581015

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


× No keyword cloud information.
  41 in total

1.  Factor XI (plasma thromboplastin antecedent) deficiency in cattle.

Authors:  P A Gentry; S Crane; F Lotz
Journal:  Can Vet J       Date:  1975-06       Impact factor: 1.008

2.  ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.

Authors:  D DEYKIN; S WESSLER
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

3.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

4.  LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.

Authors:  S SHAW; G D PEGRUM; S WOLFF
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

Review 5.  [THE STUART-PROWER FACTOR: ITS COAGULATION PHYSIOLOGY AND CLINICAL SIGNIFICANCE].

Authors:  V HIEMEYER; M H HOERDER
Journal:  Klin Wochenschr       Date:  1964-11-15

6.  Levels of blood-coagulation factors during anticoagulant therapy with phenindione.

Authors:  K W DENSON
Journal:  Br Med J       Date:  1961-04-29

7.  Isolation and characterization of vitamin K-dependent region of bovine blood clotting factor X.

Authors:  J B Howard; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

8.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Authors:  M MacIomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

10.  Familial protein S deficiency is associated with recurrent thrombosis.

Authors:  P C Comp; R R Nixon; M R Cooper; C T Esmon
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.